Ethnopharmacological relevance Interstitial lung disease (ILD) is a chronic lung dysfunction
disease with a poor prognosis and poor recovery. The clinically used therapeutic drugs …

Ethnopharmacological relevance Pulmonary fibrosis (PF) is a chronic, debilitating and often
lethal lung disorder. Despite the molecular mechanisms of PF are gradually clear with …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung scarring condition with
the histological characteristic of typical interstitial pneumonia. Injury to alveolar epithelial …

Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of
etiologies. The disease can eventually lead to irreversible damage to the lung tissue …

Ethnic pharmacological relevance Pulmonary fibrosis (PF) is a fibrotic interstitial lung
disease caused by continuous damage and excessive repair of alveolar epithelial cells, the …

Ethnopharmacological relevance Chronic obstructive pulmonary disease (COPD) is the third
leading cause of death globally and thus imposes heavy economic burden on patients, their …

Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite
treatment options. Multiple factors such as oxidative and immune/inflammation involve key …

Background: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited
treatment options. It also leads to progressive respiratory failure, which subsequently affects …

Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary interstitial inflammatory
disease of unknown etiology, and is also a sequela in severe patients with the Coronavirus …

Lung cancer stands as one of the most prevalent malignancies worldwide, bearing the
highest morbidity and mortality rates among all malignant tumors. The treatment of lung …